Skip to main content
H

HEXIMA LIMITED. — Investor Relations & Filings

Ticker · HXL ISIN · AU0000111932 ASX Professional, scientific and technical activities
Open in API
Filings indexed 245 across all filing types
Latest filing 2026-04-29 Regulatory Filings
Country AU Australia
Listing ASX HXL

About HEXIMA LIMITED.

https://hexima.com.au/

Hexima Limited focuses on the research and development of plant-derived proteins for human therapeutic applications. The company's primary development candidate is pezadeftide (HXM163), a proprietary plant defensin formulated as a topical treatment for onychomycosis, a fungal nail infection. Pezadeftide is engineered to penetrate the nail plate and target underlying fungal pathogens. The company's technology platform utilizes the natural defense mechanisms of plants to develop novel antimicrobial and antifungal treatments. Originally focused on agricultural biotechnology, the company transitioned to human health to address unmet needs in dermatology. Its activities involve the clinical evaluation of protein-based therapies designed to offer improved efficacy and safety profiles compared to existing antifungal treatments.

Recent filings

Filing Released Lang Actions
Business Activity Statement & Appendix 4C - Mar-2026 Qtr 6 pages 1.1MB
Regulatory Filings
2026-04-29 English
Results of Meeting 2 pages 129.8KB
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is an ASX announcement detailing the voting results of a General Meeting (including poll figures and resolutions passed). It provides official results from shareholder votes in accordance with the Corporations Act and ASX Listing Rules. This matches the definition for Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-04-15 English
Update - Consolidation/Split - HXL 4 pages 16.3KB
Share Issue/Capital Change Classification · 1% confidence The document is an ASX ‘Appendix 3A.3 – Notification of security consolidation or split,’ detailing the timetable and approvals for a share consolidation event (3-for-4 cancellation/consolidation). It is a formal announcement of a capital structure change (share consolidation/split), which matches the definition of Share Issue/Capital Change (SHA).
2026-04-15 English
Update - Notification of cash return of capital 9 pages 135.1KB
Share Issue/Capital Change Classification · 1% confidence The document is an ASX Appendix 3A.4 form titled “Notification of cash return of capital,” detailing a corporate action (return of capital) with record dates, payment dates, and approvals for ASX lodgement. This is not a dividend notice, financing update, or full report but a capital structure change (return of capital), fitting the “Share Issue/Capital Change” category.
2026-04-15 English
Notice of General Meeting and Proxy Form 16 pages 710.7KB
Regulatory Filings
2026-03-12 English
Notification of cash return of capital 9 pages 131.2KB
Regulatory Filings
2026-03-12 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.